StockData
Kestra Medical Technologies, Ltd. logo

Kestra Medical Technologies, Ltd. (KMTS) income statement

KMTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends April 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 5/30
$28.29+0.02 (+0.07%)

Close on Nov 18, 2026Market cap $1.69BP/E –Yield –

Kestra Medical Technologies, Ltd. income statement

Ratios

Latest available, balances at Jul 31, 2026

Profitability, TTM

Gross margin
53.9%
Operating margin
-134.5%
Net margin
-140.4%
Return on equity, FY2026
–

Financial strength

Current ratio
4.69
Debt to equity
–
Debt to assets
20.9%
Cash to current liabilities
142.0%

Valuation

P/E ratio
–
Price to sales
15.79
Price to book
–
Dividend yield
–

See a number that looks wrong?